Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1997 Dec;6(5-6):369–374. doi: 10.1080/09629359791514

Cromoglycate and nedocromil enhanced the reactive oxygen species-dependent suppressions with, but not without, dexamethasone in ischaemic and histamine paw oedema of mice

Y Oyanagui 1,2
PMCID: PMC2365879  PMID: 18472872

Abstract

Anti-inflammatory actions of two anti-allergic drugs, alone or with dexamethasone (Dex) were examined in two models, because inflammation is claimed to be important for allergic events, especially for asthma. Cromoglycate and nedocromil were tested in ischaemic- and histamineinduced paw oedema models of mice. These antiallergic drugs (1–100 mg/kg, i.p.) failed to suppress these oedemata, but enhanced the suppressions by a low dose of dexamethasone (0.1 mg/kg, s.c.) at 3–8 h after Dex injection. The mode of effects by anti-allergic drugs resembled that of a natural antioxidant (α-tocopherol, β-carotene etc.), and was different from that of an immunosuppressant like FK506. The enhancing potencies of the two anti-allergic drugs were similar at 6 h after Dex in both oedemata, and were diminished by superoxide dismutase (SOD) or catalase (i.p.). Cycloheximide completely abolished suppressions. Nedocromil, but not cromoglycate, inhibits inflammatory events. Therefore, there are common unknown actions by which the two anti-allergics enhance suppression by Dex. A possible mechanism of this action was supposed to enhance the superoxide and/or hydrogen peroxide-dependent glucocorticoid receptor (GR) signalling in the target cells.

Full Text

The Full Text of this article is available as a PDF (190.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdelaziz M. M., Devalia J. L., Khair O. A., Rusznak C., Calderon M., Sapsford R. J., Bayram H., Davies R. J. The effect of nedocromil sodium on human airway epithelial cell-induced eosinophil chemotaxis and adherence to human endothelial cell in vitro. Eur Respir J. 1997 Apr;10(4):851–857. [PubMed] [Google Scholar]
  2. Blackwell G. J., Carnuccio R., Di Rosa M., Flower R. J., Parente L., Persico P. Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature. 1980 Sep 11;287(5778):147–149. doi: 10.1038/287147a0. [DOI] [PubMed] [Google Scholar]
  3. Devalia J. L., Rusznak C., Abdelaziz M. M., Davies R. J. Nedocromil sodium and airway inflammation in vivo and in vitro. J Allergy Clin Immunol. 1996 Nov;98(5 Pt 2):S51–S66. [PubMed] [Google Scholar]
  4. Dixon M., Jackson D. M., Richards I. M. The action of sodium cromoglycate on 'C' fibre endings in the dog lung. Br J Pharmacol. 1980 Sep;70(1):11–13. doi: 10.1111/j.1476-5381.1980.tb10898.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Eady R. P. The pharmacology of nedocromil sodium. Eur J Respir Dis Suppl. 1986;147:112–119. [PubMed] [Google Scholar]
  6. Lapa e Silva J. R., Ruffié C., Vargaftig B. B., Pretolani M. Modulation of the bronchial inflammation in sensitized guinea-pigs by FK506, nedocromil sodium and dexamethasone. Eur Respir J. 1995 Aug;8(8):1321–1327. doi: 10.1183/09031936.95.08081321. [DOI] [PubMed] [Google Scholar]
  7. Leung K. B., Flint K. C., Brostoff J., Hudspith B. N., Johnson N. M., Pearce F. L. A comparison of nedocromil sodium and sodium cromoglycate on human lung mast cells obtained by bronchoalveolar lavage and by dispersion of lung fragments. Eur J Respir Dis Suppl. 1986;147:223–226. [PubMed] [Google Scholar]
  8. Ning Y. M., Sánchez E. R. Potentiation of glucocorticoid receptor-mediated gene expression by the immunophilin ligands FK506 and rapamycin. J Biol Chem. 1993 Mar 25;268(9):6073–6076. [PubMed] [Google Scholar]
  9. Okayama Y., Benyon R. C., Rees P. H., Lowman M. A., Hillier K., Church M. K. Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine. Clin Exp Allergy. 1992 Mar;22(3):401–409. doi: 10.1111/j.1365-2222.1992.tb03102.x. [DOI] [PubMed] [Google Scholar]
  10. Owens-Grillo J. K., Hoffmann K., Hutchison K. A., Yem A. W., Deibel M. R., Jr, Handschumacher R. E., Pratt W. B. The cyclosporin A-binding immunophilin CyP-40 and the FK506-binding immunophilin hsp56 bind to a common site on hsp90 and exist in independent cytosolic heterocomplexes with the untransformed glucocorticoid receptor. J Biol Chem. 1995 Sep 1;270(35):20479–20484. doi: 10.1074/jbc.270.35.20479. [DOI] [PubMed] [Google Scholar]
  11. Oyanagui Y. Immunosuppressants and TGF-beta 1 accelerated and prolonged the nitric oxide/oxyradicals-dependent suppression by dexamethasone in paw edema of mice. Life Sci. 1996;58(17):PL287–PL294. doi: 10.1016/0024-3205(96)00119-1. [DOI] [PubMed] [Google Scholar]
  12. Oyanagui Y., Sato S. Heparin, a potent releasing agent of extracellular superoxide dismutase (EC-SOD C), suppresses ischaemic paw oedema in mice. Free Radic Res Commun. 1990;9(2):87–99. doi: 10.3109/10715769009148576. [DOI] [PubMed] [Google Scholar]
  13. Oyanagui Y., Suzuki S. Vasoregulin, a glucocorticoid-inducible vascular permeability inhibitory protein. Agents Actions. 1986 Jan;17(3-4):270–277. doi: 10.1007/BF01982619. [DOI] [PubMed] [Google Scholar]
  14. Rubin R. P., Thompson R. H., Naps M. S. Differential inhibition by nedocromil sodium of superoxide generation elicited by platelet activating factor in human neutrophils. Agents Actions. 1990 Nov;31(3-4):237–242. doi: 10.1007/BF01997614. [DOI] [PubMed] [Google Scholar]
  15. Schenk H., Klein M., Erdbrügger W., Dröge W., Schulze-Osthoff K. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1. Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1672–1676. doi: 10.1073/pnas.91.5.1672. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES